Supplementary Figure S1 from Validation of the OncoMasTR Risk Score in Estrogen Receptor–Positive/HER2-Negative Patients: A TransATAC study
Richard Buus, Ivana Šestak, Stephen A. Barron, Tony Loughman, Bozena Fender, Cesar Lopez Ruiz, Peter Dynoodt, Chan‐Ju Angel Wang, Des O'Leary, William M. Gallagher, Mitch Dowsett, Jack M. Cuzick · 2023
Discovery and development of the OncoMasTR algorithm. ARACNe, Algorithm for the Reconstruction of Accurate Cellular Networks; ChIP, chromatin immunoprecipitation; MTR, master transcriptional regulator; RT-qPCR, reverse transcriptase quantitative polymerase chain reaction